UiPath Inc. (NYSE:PATH) Shares Sold by Vontobel Holding Ltd.

Vontobel Holding Ltd. decreased its holdings in UiPath Inc. (NYSE:PATH - Free Report) by 30.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 179,482 shares of the healthcare company's stock after selling 80,409 shares during the quarter. Vontobel Holding Ltd.'s holdings in UiPath were worth $4,458,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Lecap Asset Management Ltd. purchased a new position in UiPath in the 4th quarter worth about $1,661,000. Simplicity Solutions LLC raised its position in UiPath by 4.9% in the 4th quarter. Simplicity Solutions LLC now owns 12,691 shares of the healthcare company's stock worth $315,000 after buying an additional 598 shares during the last quarter. Friedenthal Financial bought a new stake in shares of UiPath during the 4th quarter valued at about $743,000. Tennessee Valley Asset Management Partners bought a new stake in shares of UiPath during the 4th quarter valued at about $50,000. Finally, Harbor Investment Advisory LLC bought a new stake in shares of UiPath during the 4th quarter valued at about $61,000. Hedge funds and other institutional investors own 62.50% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Morgan Stanley boosted their price target on UiPath from $17.00 to $25.00 and gave the company an "equal weight" rating in a research note on Thursday, March 14th. DA Davidson boosted their price target on UiPath from $20.00 to $24.00 and gave the company a "neutral" rating in a research note on Thursday, March 14th. BMO Capital Markets boosted their price target on UiPath from $24.00 to $28.00 and gave the company a "market perform" rating in a research note on Thursday, March 14th. Evercore ISI boosted their price target on UiPath from $24.00 to $27.00 and gave the company an "in-line" rating in a research note on Thursday, March 14th. Finally, William Blair assumed coverage on UiPath in a research note on Tuesday, January 2nd. They set an "outperform" rating for the company. Nine investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, UiPath currently has an average rating of "Moderate Buy" and a consensus target price of $27.41.


Get Our Latest Research Report on UiPath

Insiders Place Their Bets

In other news, CFO Ashim Gupta sold 40,000 shares of the company's stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $21.66, for a total transaction of $866,400.00. Following the sale, the chief financial officer now directly owns 660,762 shares of the company's stock, valued at approximately $14,312,104.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders sold 72,000 shares of company stock worth $1,591,360 in the last three months. 31.03% of the stock is owned by company insiders.

UiPath Stock Down 0.4 %

PATH stock traded down $0.09 during midday trading on Thursday, hitting $19.04. The company's stock had a trading volume of 4,722,430 shares, compared to its average volume of 8,959,758. UiPath Inc. has a 12 month low of $12.38 and a 12 month high of $27.87. The firm has a market capitalization of $10.83 billion, a price-to-earnings ratio of -111.96 and a beta of 0.96. The company has a 50 day moving average of $22.97 and a two-hundred day moving average of $21.44.

UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The business had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. On average, analysts anticipate that UiPath Inc. will post -0.04 earnings per share for the current fiscal year.

UiPath Company Profile

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Recommended Stories

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Should you invest $1,000 in UiPath right now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Featured Articles and Offers

5 Tech Stocks to Buy Now

5 Tech Stocks to Buy Now

In this video, we discuss technology stocks, spotlighting five promising picks to consider adding to your portfolio ahead of the Q1 earnings reports.

Search Headlines: